Try our beta test site
1 study found for:    7823668 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Asparaginase;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Daunorubicin;   Drug: Mercaptopurine;   Drug: Prednisone;   Drug: Vincristine;   Drug: Methotrexate;   Procedure: Intrathecally treatment

Study has passed its completion date and status has not been verified in more than two years.